{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1146.1599","meta":{"versionId":"7","lastUpdated":"2022-01-18T01:02:45.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1599","version":"20220118","name":"HIV Infection (ARV CCR5 Antagonists) (RXNORM)","status":"active","date":"2022-01-18T01:02:45-05:00","publisher":"CSTE Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1857911","display":"maraviroc 25 MG Oral Tablet"},{"code":"1857913","display":"maraviroc 25 MG Oral Tablet [Selzentry]"},{"code":"1857915","display":"maraviroc 75 MG Oral Tablet"},{"code":"1857917","display":"maraviroc 75 MG Oral Tablet [Selzentry]"},{"code":"1857921","display":"maraviroc 20 MG/ML Oral Solution"},{"code":"1857925","display":"maraviroc 20 MG/ML Oral Solution [Selzentry]"},{"code":"728223","display":"maraviroc 150 MG Oral Tablet"},{"code":"728225","display":"maraviroc 300 MG Oral Tablet"},{"code":"729201","display":"maraviroc 150 MG Oral Tablet [Selzentry]"},{"code":"729203","display":"maraviroc 300 MG Oral Tablet [Selzentry]"}]}]}}